Evaluating the Effects of GnRH agonist (0.1, 0.2, and 0.3 diphereline) in triggering of final oocyte maturation in infertile wome
Phase 3
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT20190409043212N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Infertile women with aged between 20-40 years
Women with FSH levels under 12
Women with menstrual cycles between 25 and 34 days
Women with both Ovary
Exclusion Criteria
Ovarian hyper stimulation and very low responses
Follicular stimulating hormone >= 12
Anti-mullerian hormone=<1
Antral follicular count < 7
Any glandular disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber and quality of oocytes. Timepoint: After Pickup. Method of measurement: sonography.;Number and quality of embryos. Timepoint: After fertilization. Method of measurement: Sonography.;Implantation. Timepoint: After trnasfer. Method of measurement: BHCG test.
- Secondary Outcome Measures
Name Time Method